Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [2][9]. Core Insights - The increase in Indonesia's crude palm oil export levy from 10% to 12.5% is expected to enhance the profitability per ton for the company's operations in Indonesia [3][4]. - The company is positioned as a leading enterprise in domestic oil chemical, surfactants, and personal care processing, with significant production capacities exceeding 1 million tons per year for oil chemical products and over 1.2 million tons for surfactants [3][9]. - The company anticipates revenue growth of 39% in 2025, followed by 16% in 2026 and 8% in 2027, with net profit projections of 3.0 billion, 4.1 billion, and 5.1 billion yuan respectively during the same period [3][9]. Summary by Relevant Sections Tax Rate Impact - The increase in the export levy is expected to boost the absolute tax amount paid, thereby enhancing the profitability of the company's Indonesian subsidiary, Dukuda [4][6]. Production Capacity and Profitability - Dukuda's new production capacity is being released in an orderly manner, and the combination of increased tax revenue and production capacity is expected to lead to simultaneous volume and price increases, enhancing overall profitability [6][9]. - The utilization rates for surfactants and OEM/ODM processing are steadily improving, which is anticipated to drive profitability upward [7]. Future Growth Potential - The company is focusing on the gradual ramp-up of OPO structured fat production, which is projected to achieve sales in the kiloton range within the year [8]. - The company has secured contracts with major clients such as White Cat and Unilever, which will help improve the operational rates of its processing capacity [7].

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [2][9]. Core Views - The increase in Indonesia's crude palm oil export levy from 10% to 12.5% is expected to enhance the profitability per ton for the company's Dukuda operations in Indonesia [3][4]. - The Dukuda project is progressing steadily, with new capacity expected to be released in an orderly manner, which, combined with the increased tax, is anticipated to achieve both volume and price growth [3][6]. - The utilization rates for surfactants and OEM/ODM processing are continuously improving, which is expected to drive profitability upward [3][7]. - The company is poised to gradually ramp up its OPO structured fat production, with expectations of achieving significant sales within the year [3][8]. Financial Projections - The company is projected to generate revenues of 14.9 billion, 17.3 billion, and 18.8 billion yuan for the years 2025, 2026, and 2027, respectively, with year-on-year growth rates of 39%, 16%, and 8% [3][9]. - The net profit attributable to the parent company is expected to be 300 million, 410 million, and 510 million yuan for the same years, reflecting year-on-year growth rates of 119%, 37%, and 24% [3][9]. - The diluted EPS is forecasted to be 0.63, 0.87, and 1.08 yuan, with corresponding P/E ratios of 19.6, 14.2, and 11.4 times [3][9].

Group 1 - The company reported a 60% profit growth in the first quarter, raising concerns about potential underperformance in the second quarter [2] - The company stated that it adheres to the information disclosure regulations set by the Shenzhen Stock Exchange [2] - The production capacity utilization rates for 2024 are 74.93% for surfactants (AES/AOS/LAS, etc.) and 90.29% for fatty chemicals (stearic acid, hydrogenated oil, monoglycerides, oleic acid, etc.) [2] Group 2 - The company advised investors to monitor relevant announcements for updates on second-quarter performance and the latest operational rates [2]

Group 1: Company Overview and Strategy - As of May 9, 2025, the number of shareholders is 16,944 [2] - The company aims to become a global leader in chemical manufacturing services by focusing on surfactants, fatty chemicals, and personal care OEM/ODM [2][3] - Future development plans include enhancing technological innovation and extending the industrial chain, particularly in Indonesia and Malaysia [3] Group 2: Financial Performance and Projections - In 2024, exports accounted for 36.55% of total sales, targeting markets such as the Belt and Road Initiative, RCEP, and Africa Free Trade Area [3] - Non-operating income from government subsidies in 2024 is projected to be CNY 3,500 million [3] - The company anticipates a significant increase in net profit for 2024, despite a decline in cash flow due to rising raw material prices [3][4] Group 3: Market Trends and Challenges - The domestic market for anionic surfactants is expected to grow by 10.5% and 14.0% in 2024, with an annual growth rate of over 8% for the surfactant market [4] - The company faces challenges from intensified competition and economic pressures, impacting profit margins compared to 2021 [7][10] - The palm oil market is currently at a reasonable level, with future price movements driven by supply and demand fundamentals [8] Group 4: Operational Efficiency and Cost Management - The company is enhancing supply chain efficiency and inventory management to reduce costs [6][10] - Automation initiatives are in place to improve production efficiency and reduce operational costs [10] - The company is committed to maintaining a minimum cash dividend of 10% of distributable profits annually [5][6] Group 5: Shareholder Engagement and Market Position - The company is considering increasing its dividend payout to enhance shareholder value [6] - As a leading player in the surfactant and fatty chemical sectors, the company holds over 30% market share in both categories [10][11] - The company is focused on maintaining independence and compliance with regulatory standards amid concerns about major shareholders [11]